Track the UNI stock price and the full insider trade history of the company, a listed equity based in Australia. Shares are quoted on the AU market, under the supervision of ASX. Operating in the Health Care sector, UNI has logged 7 reports. Market capitalisation: €622.2m. The latest transaction was disclosed on 31 August 2026 (Change in Substantial Holding). Among the most active insiders: Affiliates. Every trade is openly available.
Analysts rate UNI Strong Buy (bullish), based on 10 analysts. Average price target: A$10.30.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
7 of 7 declarations
UNI es una empresa farmacéutica y de atención médica que cotiza en el XASX. Se especializa en el desarrollo de soluciones innovadoras para mejorar la salud del paciente.